You have no items in your shopping cart.
On Promotion 
Species Host
Tested Applications
Predicted Reactivity
Conjugation
Featured Product
JAK1-IN-8 [orb1694218]98.36%
1973485-18-5
442.51
C22H23FN4O3S
5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 1 ml x 10 mM (in DMSO)- WHI-P154 [orb1225686]
>98%(HPLC)
211555-04-3
376.2
C16H14BrN3O3
100 mg, 2 mg, 5 mg, 10 mg, 1 g, 500 mg, 200 mg, 25 mg, 50 mg - Tofacitinib [orb1224990]
>98% (HPLC)
477600-75-2
312.4
C16H20N6O
1 g, 10 mg, 25 mg, 50 mg, 100 mg, 5 mg, 200 mg, 500 mg - Pyridone 6 [orb1225022]
>98%(HPLC)
457081-03-7
309.3
C18H16FN3O
1 g, 500 mg, 10 mg, 25 mg, 50 mg, 100 mg, 2 mg, 5 mg - GLPG0634 analogue [orb1223391]
>98% (HPLC)
1206101-20-3
425.5
C21H23N5O3S
1 g, 100 mg, 50 mg, 2 mg, 5 mg, 10 mg, 25 mg, 500 mg - Peficitinib [orb1223560]
>98% (HPLC)
944118-01-8
326.4
C18H22N4O2
500 mg, 200 mg, 5 mg, 50 mg, 100 mg, 10 mg, 1 g - Ruxolitinib S enantiomer [orb1223574]
>98% (HPLC)
941685-37-6
306.4
C17H18N6
1 g, 500 mg, 200 mg, 10 mg, 50 mg, 100 mg, 5 mg - Ruxolitinib [orb1223575]
>98% (HPLC)
941678-49-5
306.4
C17H18N6
1 g, 500 mg, 5 mg, 10 mg, 25 mg, 100 mg, 200 mg, 50 mg - Baricitinib (Phosphate) [orb1226852]
>98%(HPLC)
1187595-84-1
469.4
C16H20N7O6PS
5 mg, 500 mg, 1 g, 2 mg, 10 mg, 25 mg, 50 mg, 100 mg - Baricitinib [orb1226853]
>98%(HPLC)
1187594-09-7
371.4
C16H17N7O2S
2 mg, 1 g, 500 mg, 200 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg